Bio Impact Capital LLC G1 Therapeutics, Inc. Transaction History

Bio Impact Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $1.07 Million - $2.79 Million	-206,798 Reduced 24.14%	650,000 $3.53 Million
Q4 2021 Feb 11, 2022	SELL	$10.16 - $16.17 $37,632 - $59,893	-3,704 Reduced 0.43%	856,798 $8.75 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $627,837 - $1.07 Million	47,708 Added 5.87%	860,502 $11.5 Million
Q2 2021 Aug 13, 2021	SELL	$19.57 - $26.32 $2.25 Million - $3.03 Million	-115,000 Reduced 12.39%	812,794 $17.8 Million
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $8.72 Million - $16.2 Million	-496,000 Reduced 34.84%	927,794 $22.3 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $29.2 Million - $44.1 Million	1,423,794 New	1,423,794 $37.6 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.